Zhenhua Chen

9PUBLICATIONS
97CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursMolecular targetsPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2026
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimetics.

|Dec 15, 2025
Pharmacological inhibition of miR-126 enhances venetoclax activity in acute myeloid leukemia.

Lianjun Zhang, HyunJun Kang, Melissa Valerio

|Aug 15, 2025
FTO degrader impairs ribosome biogenesis and protein translation in acute myeloid leukemia.

Wenlong Li, Yutao Zhao, Dong Wu

|Aug 01, 2025
ALKBH1 Drives Tumorigenesis and Drug Resistance via tRNA-decoding Reprogramming and Codon-biased Translation.

Chao Shen, Yuan Che, Keren Zhou

|May 06, 2025
m6A/IGF2BP3-driven serine biosynthesis fuels AML stemness and metabolic vulnerability.

Feng Huang, Yushuai Wang, Xiuxin Zhang

|Apr 20, 2024
8-Cl-Ado and 8-NH2-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemia.

Jiamin Guo, Ralf Buettner, Li Du

Pageof 2

Frequent Collaborators

8 joint publications

Jianjun Chen

5 joint publications

Guido Marcucci

3 joint publications

Bin Zhang

3 joint publications

Ying Qing